Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 USD | -1.41% | -2.62% | +42.78% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.78% | 71.77M | |
+53.70% | 63.85B | |
-2.01% | 41.83B | |
+39.92% | 40.47B | |
-10.22% | 27.17B | |
+14.17% | 26.52B | |
-20.13% | 18.69B | |
+3.29% | 12.73B | |
+22.52% | 12.11B | |
+28.68% | 12.07B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Jefferies Downgrades Instil Bio to Hold From Buy